We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. ×
Market Research Report

Global Digital Therapeutics (DTx) Market Analysis by Product type & Categories, by application areas and by sales channel With COVID-19 impact | Forecast Period 2017-2030

Published Date :

2020-09-01

Report Pages :

789

Format :

PDF/PPT/XLS/Hard Copy

Region Covered :

Global

Digital Therapeutics(DTx) Market Landscape

Digital therapeutics supply the evidence-based therapeutic interventions to patients to prevent, manage, or treat a medical disorder or disease. Digital Health Landscape is expanding in the market with products like:

  1. mHealth (include Wellness, fitness trackers, and nutrition apps Medication adherence apps & Consumer health information)
  2. Digital Therapeutics
  3. Devices, Sensors, and Wearables (include Wearable and wireless devices, Biometric sensors, Diagnostic products)
  4. Health Information Technology (include Electronic medical record systems, Electronic prescribing and order entry, Consumer health IT applications)
  5. Personalized Healthcare (include Patient reported outcomes, Predictive analytics, Clinical decision support)
  6. Telehealth (include Telemedicine virtual visits, Remote patient monitoring, Remote care programs)

Global digital therapeutics market is set to triple in size over the next seven years, blossoming into a USD 10 billion opportunity — and Goldstein Research predicts consumer adoption of the digital treatments will grow more than 12-fold by 2028, which is poised to expand the DTx market at a CAGR of 20.12%.

Benefits For Pharmaceutical Firms And Medical Device Makers

Driven pharmaceutical businesses and medical device manufacturers can reap profit from digital therapeutics growth through collaborations/tie-ups with vendors that give the official access to stack of real-time data furthermore the possibility to inflate the revenue opportunities through commercializing new products and services. However, inactive drug and device manufacturers tends to jeopardize the consumers opting for digital solutions.

Drivers & Challenges to Market Growth

  • Digital therapeutics will favor the target illness that are crudely addressed by the healthcare infrastructure today, such as chronic diseases, cardiovascular disorders or neurological disorders. In addition, digital therapeutics tend to provide treatment more low-prices than traditional therapy by lessen demands on clinicians’ time. And all the while, more evidence are appering to indicate DTx value in clinical terminology.
  • The change sparked by the advent of digital medicines threatens to reshape the entire healthcare value chain. Because drugs interact with nearly every healthcare stakeholder, DTx solutions are leading a variety of players to carve out room for digital solutions: Pharmacy benefit managers (PBMs) are creating logs for DTx as they would drugs, insurers are linking their members up with digital solutions in an effort to mitigate spending, and entrenched pharma and medtech companies are tying up with digital therapeutic vendors to dip into advance revenue streams.
  • However, digital therapeutics as a segment is often not distinguished from the digital health and well-being market, which includes anything from sleep trackers to fitness apps. In addition, the incentives for providers, payors, and pharmaceutical companies to adopt digital therapeutics are not well aligned.

Digital Therapeutics Product Portfolio

The types of interventions being delivered by digital therapeutic products across the industry are as diverse as the disease states being addressed. As the digital therapeutic field grows, patients, providers, and payers can expect to see an increasingly comprehensive network of therapy options for physical, mental, and behavioral disease states. Examples of digital therapeutic product/software in the market or under-development are as follow:

  • Combined software and hardware program to improve asthma and COPD control and optimize healthcare utilization
  • Digital therapeutic utilizing adaptive sensory stimulus software for the treatment of ADHD delivered through an engaging video game experience
  • Digital therapeutic used as an adjunct to standard, outpatient treatment for Substance Use Disorder (SUD)
  • Digital sleep improvement program featuring Cognitive Behavioral Therapy (CBT) techniques
  • Digital therapeutic engaging individuals with Type 2 diabetes, hypertension, and obesity, and their providers, to improve self-management and outcomes
  • AI-based digital diagnostics and personalized therapeutics for pediatric behavioral healthcare
  • Neurologic Music Therapy to address motor, speech, and cognitive dysfunction caused by neurologic disease or injury
  • Digital delivery of physical exercises, behavioral therapy, and education for chronic back pain patients
  • Personalized digital program to help people prevent the onset of diabetes and other chronic diseases
  • Intervention tool to train cognition in concussion patients
  • Basal insulin dose calculator for adults with Type 2 diabetes

Digital Therapeutics Market Segmentation

By Product Type

  • Hardware Products
  • Solutions/Software
  • Service

By Product Categories

  • Address A Medical Condition
  • Prevention Of Medical Disorder Or Disease
  • Medication Optimization
  • Treatment Of Medical Disease Or Disorder

By Application Areas

  • Prevention Areas
  • Prediabetes
  • Obesity
  • Care Areas
  • Diabetes
  • Cardiovascular Disorders
  • Chronic Respiratory Disease
  • Central Nervous System (CNS) Disorder
  • Smoking Cessation
  • Musculoskeletal Disorder
  • Other Miscellaneous Disorders

By Sales Channel

  • B2B
  • B2C

By Geographies

  • North America Digital Therapeutic Market Analysis, 2018-2030 (US, Canada)
  • Europe Digital Therapeutic Market Analysis, 2018-2030 (Germany, UK, Russia, Spain, France, Italy, BENELUX, Switzerland and Rest of Europe)
  • Latin America Digital Therapeutic Market Analysis, 2018-2030 (Mexico, Brazil & Rest of Latin America)
  • Asia Pacific Digital Therapeutic Market Analysis, 2018-2030 (China, India, Japan, Australia, South Korea, New Zealand, Singapore, Philippine & Rest of APAC)
  • Middle East Digital Therapeutic Market Analysis, 2018-2030 (UAE, Saudi Arabia, Turkey, Iran, Qatar, Kuwait and Rest of Middle East)
  • Africa Digital Therapeutic Market Analysis, 2018-2030 (South Africa, Algeria, Nigeria, Kenya and Rest of Africa)

CogniFit is into DTx market since 20 years, offers scientifically validated tasks to precisely measure and train cognitive skills. CogniFit provide the users to identify possible cognitive alterations and cognitive deficiencies, and to create a personalized brain training regimen for their particular needs. Their client portfolio includes Bayer (leader in the pharmaceutical industry), Reckitt Benckiser (leader in health, hygiene and home products), Medica (health insurance), etc. The CogniFit brain training program for adults with dyslexia is a neuroscientific program specifically designed to improve mental sharpness. The training helps boost reading and writing skills, enhances concentration, memory, and learning ability.

Omada Health is conducting the preeminent design and web technology to digital health. Omanda Health custom-made digital care programs for prevention are for type 2 diabetes, hypertension, and behavioral health which address the whole person to empower healthy patterns that can last.

One of the main player in PDT (Prescription Digital Therapeutics), Pear Therapeutics aim to reexplore medicine by discovering, developing, and delivering clinically validated PDTs to allow better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear Therapeutics has a pipeline of products and product candidates across therapeutic areas, comprising severe psychiatric and neurological conditions. Their foremost innovation, reSET, was the first prescription digital therapeutic to receive marketing authorization from the FDA to treat Substance Use Disorder and 2 nd product, reSET-O received marketing authorization from the FDA in December 2018 for the treatment of Opioid Use Disorder.

Covered in this Global Digital Therapeutics(DTx) Market report 

  • Helps the reader to understand the country specific landscape in the digital therapeutics, the recent trends, and challenges. Moreover, the report also outlines enterprises' investment priorities in the healthcare sector
  • The most exhaustive and up-to-date report providing revenue opportunity forecasts in the digital therapeutics market from 2017 to 2030, spanning various sub-segments, 6 regions and 195 countries , and investment priorities.
  • Provides the Market Size (USD Billion), Market Share (%), CAGR (%), Y-O-Y Growth Rate (%) of Global Digital Therapeutic Market ad further bifurcated into Regions & Countries.
  • The study provides an in-depth analysis with current and future trends to elucidate the imminent investment pockets in the market.
  • The report provides a detailed description about the future outlook of digital therapeutics which is the next focus area in the healthcare industry.
  • Give the roadmap to the digital therapeutics market and explains how companies developing digital drug alternatives are transforming healthcare and identifies the key operating players
  • Helps the client to explores how digital therapeutics stand to benefit and threaten entrenched players, like payers, pharmaceutical companies, and medical device makers.

For a full detailed overview, send here request for market report sample.

COVID-19 impact on "Global Digital Therapeutics(DTx) Market"    

Impact of COVID-19 Outbreak on “Global Digital Therapeutics(DTx) Market ”, Manufacturers, Contract Manufacturers Suppliers and Recovery Strategy. A complete detailed chapter of 50-70 pages which includes the data and information focused on impacts of the pandemic on the Global Digital Therapeutics(DTx) Market . It also showcases the expected recovery schedule and losses in the industry and other various major factors.

Key Market Players

Our Global Digital Therapeutics Market Report comprises of the following companies as the key players.

  1. 23andMe
  2. 2morrow, Inc.
  3. Advocate Health Care
  4. Akili Interactive
  5. Apple
  6. Aptar Pharma
  7. Aurora Health Care
  8. Bayer
  9. Better Therapeutics
  10. Big Health
  11. Biofourmis
  12. Blue Shield of California
  13. Cambia Health Solutions
  14. Cigna
  15. Click Therapeutics
  16. CogniFit
  17. Cognoa
  18. CVS Caremark
  19. DarioHealth
  20. Dexcom
  21. Diabeto
  22. Digital Therapeutic Alliance
  23. Eli Lilly
  24. ExpressScripts
  25. Glooko
  26. Happify Health
  27. Health2Sync
  28. Kaia Health
  29. Lark Health
  30. Livongo
  31. MedRhythms
  32. myStrength
  33. mySugr
  34. Noom
  35. Novartis
  36. Novo Nordisk
  37. Omada Health
  38. Omron
  39. One Drop
  40. Otsuka
  41. Pear Therapeutics
  42. Propeller Health
  43. Proteus Digital Health
  44. ResMed
  45. Retrofit
  46. Roche
  47. Sanofi
  48. Teva Pharmaceutical
  49. Teladoc
  50. UnitedHealth Group
  51. Vida Health
  52. Virta Health
  53. Voluntis
  54. Walgreens
  55. Walmart
  56. Welldoc



{ }

Global Digital Therapeutics (DTx) Market Analysis by Product type & Categories, by application areas and by sales channel With COVID-19 impact | Forecast Period 2017-2030

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Table of Contents

BROWSE SIMILAR REPORTS

Please Select Linenece Type